Substrate-Assisted Inhibition of Ubiquitin-like Protein-Activating Enzymes: The NEDD8 E1 Inhibitor MLN4924 Forms a NEDD8-AMP Mimetic In SituJames E. Brownell, Lawrence R. Dick, Michael D. Sintchak et al.|Molecular Cell|2010Cited by 461
A phase 1, first-in-human study of IK-930, an oral TEAD inhibitor targeting the Hippo pathway in subjects with advanced solid tumors.Anthony W. Tolcher, Sergio Santillana, Laura Victor et al.|Journal of Clinical Oncology|2022Cited by 49